Erythromycin dihydrate is a macrolide antibiotic used to treat various bacterial infections by inhibiting protein synthesis. The dihydrate form enhances the stability and solubility of erythromycin. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as anti-infectives. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Erythromycin A dihydrate and DA-52996. Its PubChem CID is 83991.
Erythromycin dihydrate
| CAS No | 59319-72-1 |
|---|---|
| Molecular Formula | C37H71NO15 |
| Molecular Weight | 770.0 g/mol |
| Synonyms | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;dihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Erythromycin dihydrate is a macrolide antibiotic used to treat various bacterial infections by inhibiting protein synthesis. The dihydrate form enhances the stability and solubility of erythromycin.
The listed CAS number is 59319-72-1.
The listed molecular formula is C37H71NO15.
The listed molecular weight is 770.0 g/mol.
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;dihydrate.
The source lists Erythromycin A dihydrate and DA-52996.